Skip to content
VuFind
Advanced
  • Mass drug administration trial...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation
QR Code

Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation

Bibliographic Details
Main Authors: Tisch, D., Bockarie, M., Dimber, Z., Kiniboro, B., Tarongka, N., Hazlett, F., Kastens, W., Alpers, Michael Philip, Kazura, J.
Format: Journal Article
Published: The American Society of Tropical Medicine and Hygiene 2008
Online Access:http://hdl.handle.net/20.500.11937/22081
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/22081

Similar Items

  • Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in papua new guinea
    by: Tisch, D., et al.
    Published: (2011)
  • Construction Of Human Lymphatic Filariasis Antibody Phage Display Library And Production Of Recombinant Monoclonal Antibodies Against BmR1 And BmSXP Filarial Antigens
    by: Rahumatullah, Anizah
    Published: (2018)
  • Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives
    by: Wan Sulaiman, Wan Aliaa, et al.
    Published: (2019)
  • Incidence and spatial distribution of lymphatic filariasis in Sarawak, 2018-2022
    by: Ariffin, Mohd Aslam
    Published: (2023)
  • Environmental determinants in sustaining the transmission of lymphatic filariasis: a systematic review
    by: Ahmad Farid Nazmi Abdul Halim,, et al.
    Published: (2025)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips